Analysis of a novel pncA mutation for susceptibility to Pyrazinamide therapy (2018)
Attributed to:
Newton001 Understanding Antimicrobial Resistance Mutations in Tuberculosis: Towards Personalised Treatment to Combat Multi-drug Resistance
funded by
Newton Fund
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.24673
Publication URI: https://www.repository.cam.ac.uk/handle/1810/277380
Type: Journal Article/Review